AR028375A1 - TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR - Google Patents

TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR

Info

Publication number
AR028375A1
AR028375A1 ARP010101970A ARP010101970A AR028375A1 AR 028375 A1 AR028375 A1 AR 028375A1 AR P010101970 A ARP010101970 A AR P010101970A AR P010101970 A ARP010101970 A AR P010101970A AR 028375 A1 AR028375 A1 AR 028375A1
Authority
AR
Argentina
Prior art keywords
sodium
type
hydrogen exchanger
exchanger inhibitor
inhibitor
Prior art date
Application number
ARP010101970A
Other languages
Spanish (es)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR028375A1 publication Critical patent/AR028375A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP010101970A 2000-04-28 2001-04-26 TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR AR028375A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28

Publications (1)

Publication Number Publication Date
AR028375A1 true AR028375A1 (en) 2003-05-07

Family

ID=22741697

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010101970A AR028375A1 (en) 2000-04-28 2001-04-26 TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR

Country Status (40)

Country Link
EP (1) EP1276737A1 (en)
JP (1) JP2003531900A (en)
KR (1) KR20020093079A (en)
CN (1) CN1225466C (en)
AP (1) AP2002002651A0 (en)
AR (1) AR028375A1 (en)
AU (1) AU2001235896A1 (en)
BG (1) BG107139A (en)
BR (1) BR0110268A (en)
CA (1) CA2407535A1 (en)
CO (1) CO5221125A1 (en)
CR (1) CR6797A (en)
CZ (1) CZ20023408A3 (en)
DZ (1) DZ3310A1 (en)
EA (1) EA004882B1 (en)
EE (1) EE200200615A (en)
GT (1) GT200100064A (en)
HN (1) HN2001000042A (en)
HR (1) HRP20020851A2 (en)
HU (1) HUP0300651A2 (en)
IL (1) IL152075A0 (en)
IS (2) IS6567A (en)
MA (1) MA26897A1 (en)
MX (1) MXPA02010600A (en)
MY (1) MY133842A (en)
NO (1) NO20025132L (en)
NZ (1) NZ521348A (en)
OA (1) OA12256A (en)
PA (1) PA8513301A1 (en)
PE (1) PE20011270A1 (en)
PL (1) PL357765A1 (en)
SK (1) SK14872002A3 (en)
SV (1) SV2002000418A (en)
TN (1) TNSN01065A1 (en)
TR (1) TR200202439T2 (en)
UA (1) UA73348C2 (en)
UY (1) UY26680A1 (en)
WO (1) WO2001083470A1 (en)
YU (1) YU79602A (en)
ZA (1) ZA200208605B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2436539A1 (en) * 2001-01-31 2002-08-08 Pfizer Products Inc. Ethanolates of sodium-hydrogen exchanger type-1 inhibitor
JP2005511787A (en) * 2001-12-19 2005-04-28 ファイザー・プロダクツ・インク Method for preparing sodium-hydrogen exchange type 1 inhibitor
EP1499317A1 (en) * 2002-05-02 2005-01-26 Pfizer Products Inc. Treatment of diabetes and diabetic complications with nhe-1 inhibitors
FR2840302B1 (en) * 2002-06-03 2004-07-16 Aventis Pharma Sa ISOINDOLONE DERIVATIVES, PREPARATION METHOD AND INTERMEDIARY THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME
ES2220185B1 (en) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas NEW INHIBITOR PEPTIDE OF THE NA + / H + EXCHANGER (PINHE), AND ITS APPLICATIONS.
AU2004212957A1 (en) * 2003-02-14 2004-09-02 Smithkline Beecham Corporation Novel compounds
RU2518741C1 (en) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" MEDICATION, INHIBITING Na+/H+-EXCHANGE, AND HALOGENIDES OF 1-DIALKYLAMINOETHYL-3-[SUBSTITUTED(DISUBSTITUTED)PHENACYL]-2-AMINOBENZIMIDAZOLIUM

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1454902A1 (en) * 1998-02-27 2004-09-08 Pfizer Products Inc. N- (substituted five-membered di-or triaza diunsaturated ring)carbonyl guanidine derivateives for the treatment of ischemia

Also Published As

Publication number Publication date
CN1426404A (en) 2003-06-25
ZA200208605B (en) 2003-10-24
NZ521348A (en) 2004-09-24
MXPA02010600A (en) 2003-03-10
PA8513301A1 (en) 2003-09-05
EA200201023A1 (en) 2003-02-27
IL152075A0 (en) 2003-05-29
WO2001083470A1 (en) 2001-11-08
NO20025132L (en) 2002-12-12
EE200200615A (en) 2004-04-15
TNSN01065A1 (en) 2005-11-10
CZ20023408A3 (en) 2004-01-14
UA73348C2 (en) 2005-07-15
NO20025132D0 (en) 2002-10-25
SV2002000418A (en) 2002-07-03
EA004882B1 (en) 2004-08-26
AU2001235896A1 (en) 2001-11-12
IS6567A (en) 2002-09-24
EP1276737A1 (en) 2003-01-22
IS6588A (en) 2002-10-21
HUP0300651A2 (en) 2003-07-28
DZ3310A1 (en) 2001-11-07
CA2407535A1 (en) 2001-11-08
UY26680A1 (en) 2001-12-28
BR0110268A (en) 2003-12-30
BG107139A (en) 2003-07-31
CN1225466C (en) 2005-11-02
HRP20020851A2 (en) 2005-02-28
MA26897A1 (en) 2004-12-20
YU79602A (en) 2006-05-25
SK14872002A3 (en) 2004-03-02
OA12256A (en) 2003-11-06
AP2002002651A0 (en) 2002-12-31
TR200202439T2 (en) 2003-02-21
KR20020093079A (en) 2002-12-12
MY133842A (en) 2007-11-30
HN2001000042A (en) 2001-07-09
PE20011270A1 (en) 2001-12-12
GT200100064A (en) 2002-03-22
CO5221125A1 (en) 2002-11-28
JP2003531900A (en) 2003-10-28
PL357765A1 (en) 2004-07-26
CR6797A (en) 2004-05-17

Similar Documents

Publication Publication Date Title
DE60101714D1 (en) heat exchangers
DE60012822D1 (en) heat exchangers
DE50100984D1 (en) Plate heat exchanger
DE60037879D1 (en) Heat Exchanger
DE60138964D1 (en) Heat Exchanger
DE60109107D1 (en) Plate heat exchanger
DE60138767D1 (en) Heat Exchanger
DE60116596T8 (en) Heat Exchanger
FI20000543A (en) transfer arrangement
DE10083636T1 (en) heat exchangers
DE60115565D1 (en) heat exchangers
DE60023394D1 (en) heat exchangers
DE60040609D1 (en) Heat Exchanger
DE60034017D1 (en) Heat Exchanger
DE60027489D1 (en) heat exchangers
ITMI20002039A0 (en) HEAT EXCHANGER
DE60110872D1 (en) The heat exchanger assembly
AR028375A1 (en) TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR
FI20002454A0 (en) Heat exchanger
DE60006813D1 (en) heat exchangers
ATA116899A (en) Heat Exchanger
ITMI20001583A0 (en) HEAT EXCHANGER
DE50114466D1 (en) Cross-flow radiator
NO20021821D0 (en) Sodium-hydrogen exchange type 1 inhibitor crystals
DE60102847D1 (en) heat exchangers

Legal Events

Date Code Title Description
FB Suspension of granting procedure